Takeda Pharmaceutical
TAK
#416
Rank
NZ$106.61 B
Marketcap
NZ$33.37
Share price
1.13%
Change (1 day)
39.32%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): -NZ$0.21 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.54 Billion. In 2025 the company made an earning of NZ$5.92 Billion, an increase over its 2024 earnings that were of NZ$3.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.21 Billion-103.48%
2025 NZ$5.92 B49.03%
2024 NZ$3.97 B-2.41%
2023 NZ$4.07 B-28.14%
2022 NZ$5.66 B-40.9%
2021 NZ$9.59 B78.24%
2020 NZ$5.38 B246.1%
2019 NZ$1.55 B-48.79%
2018 NZ$3.03 B-23.64%
2017 NZ$3.97 B21.7%
2016 NZ$3.26 B-253.01%
2015 -NZ$2.14 Billion-159.65%
2014 NZ$3.57 B13%
2013 NZ$3.16 B2.46%
2012 NZ$3.09 B-57.05%
2011 NZ$7.19 B-10.49%
2010 NZ$8.04 B-3.99%
2009 NZ$8.37 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B-21,333.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.65 B-12,675.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.30 B-5,695.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.33 B-8,434.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.75 B-5,901.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$13.70 B-6,330.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.05 B-6,491.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.41 Billion 540.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$0.89 B-507.73%๐Ÿ‡ฎ๐Ÿ‡ณ India